We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Regulatory News: GeNeuro (Euronext Paris : CH0308403085 - GNRO), société biopharmaceutique dont l'objectif est de s'attaquer aux facteurs de progression des maladies neurodégénératives et...
Regulatory News: GeNeuro (Euronext Paris: CH0308403085 - GNRO), a biopharmaceutical company developing new treatments for neurodegenerative and autoimmune diseases, announces that the Geneva...
Regulatory News: GeNeuro (Euronext Paris: CH0308403085 - GNRO), a biopharmaceutical company focused on addressing the factors driving the progression of neurodegenerative and autoimmune...
Regulatory News: GeNeuro (Euronext Paris : CH0308403085 – GNRO), société biopharmaceutique développant de nouveaux traitements pour les maladies neurodégénératives et auto-immunes, telles que la...
Regulatory News: La société GENEURO (Paris:GNRO) et la société GILBERT DUPONT ont mis fin au contrat de liquidité conclu le 06 mars 2021. Cette résiliation a pris effet le 30 juin 2024 au soir. A...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0528 | 64.2335766423 | 0.0822 | 0.28 | 0.0674 | 750926 | 0.1490719 | DE |
4 | 0.0125 | 10.2040816327 | 0.1225 | 0.28 | 0.066 | 412929 | 0.12041217 | DE |
12 | 0.049 | 56.976744186 | 0.086 | 0.28 | 0.0428 | 261105 | 0.12364996 | DE |
26 | -0.0145 | -9.69899665552 | 0.1495 | 0.28 | 0.0428 | 152061 | 0.11497457 | DE |
52 | -1.265 | -90.3571428571 | 1.4 | 2.35 | 0.0428 | 92667 | 0.1990246 | DE |
156 | -3.485 | -96.270718232 | 3.62 | 4.06 | 0.0428 | 34279 | 0.38361488 | DE |
260 | -3.355 | -96.1318051576 | 3.49 | 6.28 | 0.0428 | 23962 | 0.81009672 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions